Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small cell lung cancer (NSCLC) and small cell lung ...

This includes protecting mRNA treatment from degradation following administration into the body, delivering the mRNA to the appropriate target cells in the body, and mediating uptake into target ...

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small ...

Bin Wu, associate professor in the department of Biophysics and Biophysical Chemistry at the School of Medicine, visited ...

typically by binding to messenger RNA (mRNA) and triggering its degradation. The process is exploited by researchers to knock down gene expression in cell culture and in vivo in model organisms.

mRNA vaccines achieved their first success against COVID-19, but could a bigger target be next? Ben Hargreaves examines whether the technology could provide a new tool against cancer, and how ...

Another reason for choosing a particular modality is that it is a team’s specialty. Strategic choices can be less about determining which modality best fits a potential target than about choosing a ...

Moderna (MRNA) reachead $24.73 at the closing of the latest trading day, reflecting a -1.85% change compared to its last close. The Biden administration is reportedly in talks with vaccine makers ...